Literature DB >> 9205646

Gonadal hormone substitutes: effects on the cardiovascular system.

T B Clarkson1, J M Cline, J K Williams, M S Anthony.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9205646     DOI： 10.1007/bf01674813

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  64 in total

1.  Patterns and determinants of conjugated estrogen use.

Authors:  L Rosenberg; S Shapiro; D W Kaufman; D Slone; O S Miettinen; P D Stolley
Journal:  Am J Epidemiol       Date:  1979-06       Impact factor: 4.897

2.  Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited.

Authors:  E Barrett-Connor; D L Wingard; M H Criqui
Journal:  JAMA       Date:  1989-04-14       Impact factor: 56.272

3.  Oral contraceptive treatment decreases arterial low density lipoprotein degradation in female cynomolgus monkeys.

Authors:  J D Wagner; M R Adams; D C Schwenke; T B Clarkson
Journal:  Circ Res       Date:  1993-06       Impact factor: 17.367

4.  Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.

Authors:  H Z Ke; H A Simmons; C M Pirie; D T Crawford; D D Thompson
Journal:  Endocrinology       Date:  1995-06       Impact factor: 4.736

5.  Estrogen modulates responses of atherosclerotic coronary arteries.

Authors:  J K Williams; M R Adams; H S Klopfenstein
Journal:  Circulation       Date:  1990-05       Impact factor: 29.690

6.  Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group.

Authors:  L E Rutqvist; A Mattsson
Journal:  J Natl Cancer Inst       Date:  1993-09-01       Impact factor: 13.506

7.  Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques.

Authors:  J M Cline; G Soderqvist; E von Schoultz; L Skoog; B von Schoultz
Journal:  Am J Obstet Gynecol       Date:  1996-01       Impact factor: 8.661

8.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

Authors:  M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

9.  Estrogens, progestins, and coronary heart disease in cynomolgus monkeys.

Authors:  T B Clarkson
Journal:  Fertil Steril       Date:  1994-12       Impact factor: 7.329

10.  Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen.

Authors:  S Rössner; A Wallgren
Journal:  Atherosclerosis       Date:  1984-09       Impact factor: 5.162
View more
  3 in total

Review 1.  Hormone replacement therapy and cardiovascular risk.

Authors:  M Gerhard-Herman; N Hamburg; P Ganz
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

Review 2.  Ovarian steroids and serotonin neural function.

Authors:  C L Bethea; M Pecins-Thompson; W E Schutzer; C Gundlah; Z N Lu
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

3.  Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques.

Authors:  J A Henderson; C L Bethea
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.